Literature DB >> 20673037

Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?

Juan José Soler-Cataluña1, Roberto Rodriguez-Roisin.   

Abstract

Exacerbations are important events in the natural history of chronic obstructive pulmonary disease (COPD). The higher the number of COPD exacerbations, the worse are the clinical and economical consequences. The distribution of COPD exacerbations is however highly variable. Some patients do not exhibit exacerbations at all whereas others suffer frequent events (i.e., "frequent COPD exacerbators"). We review the scientific evidence regarding the impact of COPD exacerbation frequency and assess whether or not these frequent exacerbators represent a unique population of COPD patients with higher morbidity and mortality risks. A definition of "frequent COPD exacerbators" is suggested to differentiate it from other related terms, such as "treatment failure" and "recurrence." The standardization of this terminology seems to be necessary to further identify COPD phenotypes in patients who have an individual susceptibility to develop frequent exacerbations. It can also be of help to refine the most appropriate therapeutic and preventative measures.

Entities:  

Mesh:

Year:  2010        PMID: 20673037     DOI: 10.3109/15412555.2010.496817

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  11 in total

Review 1.  Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Authors:  Alvar Agustí; Peter M Calverley; Marc Decramer; Robert A Stockley; Jadwiga A Wedzicha
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  Clinical Features according to the Frequency of Acute Exacerbation in COPD.

Authors:  Seung Jun Lee; Seung Hun Lee; Yu Eun Kim; Yu Ji Cho; Yi Yeong Jeong; Ho Cheol Kim; Jin Hyun Kim; Jin Jong You; Chul-Ho Yoon; Jong Deog Lee; Young Sil Hwang
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-04-30

3.  Chronic Obstructive Pulmonary Disease.

Authors:  Sean O'Reilly
Journal:  Am J Lifestyle Med       Date:  2016-07-07

4.  The concept of control of COPD in clinical practice.

Authors:  Juan José Soler-Cataluña; Bernardino Alcázar-Navarrete; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-12-12

Review 5.  Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management.

Authors:  Josep Roca; Claudia Vargas; Isaac Cano; Vitaly Selivanov; Esther Barreiro; Dieter Maier; Francesco Falciani; Peter Wagner; Marta Cascante; Judith Garcia-Aymerich; Susana Kalko; Igor De Mas; Jesper Tegnér; Joan Escarrabill; Alvar Agustí; David Gomez-Cabrero
Journal:  J Transl Med       Date:  2014-11-28       Impact factor: 5.531

Review 6.  Prevention of COPD exacerbations: medications and other controversies.

Authors:  Jørgen Vestbo; Peter Lange
Journal:  ERJ Open Res       Date:  2015-05-06

7.  Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations.

Authors:  Yusheng Cheng; Xiongwen Tu; Linlin Pan; Shuai Lu; Ming Xing; Linlin Li; Xingwu Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-18

Review 8.  The recent advances of phenotypes in acute exacerbations of COPD.

Authors:  Aiyuan Zhou; Zijing Zhou; Yiyang Zhao; Ping Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-27

9.  Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.

Authors:  Raju Bishwakarma; Wei Zhang; Yong-Fang Kuo; Gulshan Sharma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-31

10.  AGR3 Regulates Airway Epithelial Junctions in Patients with Frequent Exacerbations of COPD.

Authors:  Rui Ye; Cuihong Wang; Pengbo Sun; Shuang Bai; Li Zhao
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.